4/A//SEC Filing
Dayno Jeffrey M. 4/A
Accession 0001415889-23-008971
CIK 0001802665other
Filed
May 30, 8:00 PM ET
Accepted
May 31, 4:37 PM ET
Size
5.7 KB
Accession
0001415889-23-008971
Insider Transaction Report
Form 4/AAmended
Dayno Jeffrey M.
DirectorPRESIDENT, CEO
Transactions
- Award
Stock Option
2023-05-26+125,000→ 125,000 totalExercise: $35.56Exp: 2033-05-25→ Common Stock (125,000 underlying)
Footnotes (2)
- [F1]This Form 4/A is being filed to amend the exercise price of the granted options previously reported as being $35.99 to $35.56.
- [F2]The stock option vests with respect to 50% of the underlying shares on May 25, 2025, with the remaining shares vesting in twenty-four equal monthly installments beginning on June 25, 2025.
Documents
Issuer
Harmony Biosciences Holdings, Inc.
CIK 0001802665
Entity typeother
Related Parties
1- filerCIK 0001615993
Filing Metadata
- Form type
- 4/A
- Filed
- May 30, 8:00 PM ET
- Accepted
- May 31, 4:37 PM ET
- Size
- 5.7 KB